EXICURE, INC. Business Combination, Contingent Consideration, Liability, Current
EXICURE, INC. (XCUR) had Business Combination, Contingent Consideration, Liability, Current of $1.21 million as of 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:BusinessCombinationContingentConsiderationLiabilityCurrent · last filed 2026-08-14
- 2026-06-30: Business Combination, Contingent Consideration, Liability, Current $1.21M.
- 2026-03-31: Business Combination, Contingent Consideration, Liability, Current $1.21M.
- 2025-12-31: Business Combination, Contingent Consideration, Liability, Current $995.00K; Business Combination, Contingent Consideration, Liability, Current as first filed $996.00K.
- 2025-09-30: Business Combination, Contingent Consideration, Liability, Current $242.00K.
| Period end | Business Combination, Contingent Consideration, Liability, Current | Business Combination, Contingent Consideration, Liability, Current as first filed |
|---|---|---|
| 2026-06-30 | $1.21M 10-Q · filed 2026-08-14 | |
| 2026-03-31 | $1.21M 10-Q · filed 2026-05-29 | |
| 2025-12-31 | $995.00K 10-Q · filed 2026-08-14 | $996.00K 10-K · filed 2026-03-25 |
| 2025-09-30 | $242.00K 10-Q · filed 2025-11-07 | |
| 2025-06-30 | $235.00K 10-Q · filed 2025-08-08 | |
| 2024-12-31 | $0.00 10-Q · filed 2025-11-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SOLIGENIX, INC. (SNGX) | United States | $0.008B | |
| Imunon, Inc. (IMNN) | United States | $0.008B | -0.56 |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| Traws Pharma, Inc. (TRAW) | United States | $0.009B | -0.58 |
| Alzamend Neuro, Inc. (ALZN) | United States | $0.009B | |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B | |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |
| FibroBiologics, Inc. (FBLG) | United States | $0.009B | -0.27 |